ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 176 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $36,000 | -96.4% | 520 | -97.4% | 0.02% | -93.8% |
| Q2 2016 | $996,000 | -76.2% | 20,379 | -69.2% | 0.26% | -67.9% |
| Q1 2016 | $4,190,000 | -29.9% | 66,189 | +24.2% | 0.80% | -4.5% |
| Q4 2015 | $5,976,000 | +54.6% | 53,272 | +32.7% | 0.84% | +63.0% |
| Q3 2015 | $3,866,000 | -25.8% | 40,142 | -21.1% | 0.51% | +2.6% |
| Q2 2015 | $5,208,000 | -41.2% | 50,874 | -64.3% | 0.50% | -36.3% |
| Q1 2015 | $8,856,000 | +255.7% | 142,634 | +151.3% | 0.79% | +252.9% |
| Q4 2014 | $2,490,000 | -60.7% | 56,749 | -49.3% | 0.22% | -62.0% |
| Q3 2014 | $6,334,000 | – | 111,920 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |